|
Volumn 74, Issue 1-3, 2001, Pages 317-323
|
Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier
|
Author keywords
Cancer therapy; Chitosan; Dextran doxorubicin; Hydrogel nanoparticles; Tumor targeting
|
Indexed keywords
CHITOSAN;
DEXTRAN DOXORUBICIN CONJUGATE;
DOXORUBICIN DERIVATIVE;
DRUG CARRIER;
NANOPARTICLE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
BIOCOMPATIBILITY;
BIODEGRADATION;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG CONJUGATION;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG PENETRATION;
DRUG RETENTION;
DRUG SAFETY;
DRUG TARGETING;
ENCAPSULATION;
HYDROGEL;
LIGHT SCATTERING;
MACROPHAGE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SOLID TUMOR;
SURVIVAL TIME;
TUMOR CELL;
TUMOR REGRESSION;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
CHITIN;
CHITOSAN;
DEXTRANS;
DOXORUBICIN;
DRUG CARRIERS;
EMULSIONS;
LIGHT;
MALE;
MICE;
MICE, INBRED BALB C;
MICROSCOPY, ELECTRON;
MICROSPHERES;
NEOPLASM TRANSPLANTATION;
NEOPLASMS, EXPERIMENTAL;
PARTICLE SIZE;
SCATTERING, RADIATION;
|
EID: 0035816156
PISSN: 01683659
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-3659(01)00342-X Document Type: Conference Paper |
Times cited : (618)
|
References (17)
|